Saturday, 24 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Sanofi Appoints Belén Garijo as New CEO to Drive R&D Innovation and Productivity
Company

Sanofi Appoints Belén Garijo as New CEO to Drive R&D Innovation and Productivity

February 13, 2026
Immunofoco Bio Files Hong Kong IPO for Solid Tumor CAR-T Pipeline
CompanyDeals

Immunofoco Bio Files Hong Kong IPO for Solid Tumor CAR-T Pipeline

February 13, 2026
Amgen’s UPLIZNA Wins European Approval for Generalized Myasthenia Gravis
CompanyDrug

Amgen’s UPLIZNA Wins European Approval for Generalized Myasthenia Gravis

February 13, 2026
CompanyDrug

Innovent Biologics Initiates Phase 3 HeriCare-Breast01 Study for IBI354 in HER2+ Breast Cancer

February 13, 2026
CompanyDeals

Ribo Life Science Licenses $4.4 Billion MASH siRNA Portfolio to Madrigal Pharmaceuticals

February 12, 2026
CompanyDeals

Novartis Secures Long-Term Actinium-225 Supply from Niowave for Radioligand Therapy Expansion

February 12, 2026
CompanyDeals

Therom Fisher’s PPD Partners with Datavant to Integrate Real-World Data into Clinical Trials

February 12, 2026
MSD’s Keytruda Wins FDA Approval for Platinum-Resistant Ovarian Cancer
CompanyDrug

MSD’s Keytruda Wins FDA Approval for Platinum-Resistant Ovarian Cancer

February 12, 2026
Sanofi Invests $30 Million in GluBio’s Sickle Cell TPD Programs
CompanyDeals

Sanofi Invests $30 Million in GluBio’s Sickle Cell TPD Programs

February 12, 2026
CompanyDrug

Henlius Biotech Initiates Phase Ib/II Study for HLX43 ADC Combinations in Colorectal Cancer

February 12, 2026
Jingxin Pharmaceutical Files Hong Kong IPO for Dual Listing Strategy
CompanyDeals

Jingxin Pharmaceutical Files Hong Kong IPO for Dual Listing Strategy

February 12, 2026
Novo Nordisk to Launch Wegovy Vial Version in Price War with Eli Lill
Company

Novo Nordisk to Launch Wegovy Vial Version in Price War with Eli Lilly

February 12, 2026
1 2 … 5 6 7 8 9 … 18 19
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up